XM02, the first granulocyte colony-stimulating factor...

XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy

Engert, A., Griskevicius, L., Zyuzgin, Y., Lubenau, H., del Giglio, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190902756081
Date:
January, 2009
File:
PDF, 236 KB
english, 2009
Conversion to is in progress
Conversion to is failed